Sunday, May 3, 2026
E-Paper
Home Blog Page 87458

Ahead of Chicago Summit Obama meets NATO Secretary General

WASHINGTON, May 10: US President Barack Obama has met with the NATO Secretary General, Anders Fogh Rasmussen to discuss the security situation in Afghanistan, ahead of the NATO Summit scheduled later this month.

Obama met the NATO top official to discuss the final preparations for the summit the US President will host in Chicago and the decisions related to Afghanistan that would be taken at the Summit.

“The President and Secretary General Rasmussen agreed that the Summit would focus on three important topics: Afghanistan, defense capabilities, and partnerships,” the White House said in a statement.

On Afghanistan, Obama and Rasmussen agreed that the NATO Summit should reaffirm allied commitment to the transition framework agreed to at Lisbon, while planning for the final stages of that transition—including a shift next year from combat to a support role, as well as enduring support for sufficient and sustainable Afghan forces.

Obama and Rasmussen also agreed that the Summit should highlight the commitment of allies to field the defense capabilities that NATO needs for the 2st century.

“They discussed their expectation that allies would be in a position to announce progress on a number of key capabilities initiatives, including on missile defense,” the White House said adding that the two discussed the importance of NATO’s partnerships with non-NATO countries.

“NATO is now a hub for a global network of security partners which have served alongside NATO forces in Afghanistan, Libya, and Kosovo.

Recognizing the important contributions provided by partner nations, the President and Secretary General welcomed the recent decision by allies to invite a group of thirteen partner nations to Chicago for an unprecedented meeting to discuss ways to further broaden and deepen NATO’s cooperation with partner nations,” the statement said. (PTI)

Kids’ TV time tied to unhealthy food choices

NEW YORK, May 10: Kids and teens who watch a lot of television are less likely to get their fruits and veggies and more likely to snack on candy or drink soda every day, according to a new survey of close to 13,000 US students. The link to poor eating habits remained even after researchers took into account how much exercise kids typically got as well as how often they snacked while in front of the tube.(agencies)

US FDA advisers back Pfizer arthritis drug

SILVER SPRING, MARYLAND, May 10: Pfizer Inc <PFE.N> won support from a US advisory panel on Wednesday for its arthritis drug, which the world’s top drugmaker hopes will give it a major boost after a wave of patent expiries. A panel of outside experts to the US Food and Drug Administration voted 8-2 to recommend approval of tofacitinib, a treatment for patients with rheumatoid arthritis who have not had success with at least one other drug for the disease. (agencies)

US Govt urged to fight fat at school

WASHINGTON, May 10: A coalition of health advocacy groups on Wednesday urged the US government to put more resources into school-based efforts to improve health and fight obesity among youth. The recommendations by the Healthy Schools Campaign and Trust for America’s Health were backed by more than 70 groups including the American Cancer Society and the National Education Association. (agencies)

Two proposed changes dropped from psychiatric guide

CHICAGO, May 10: Two proposed psychiatric diagnoses failed to make the last round of cuts in the laborious process of revising the Diagnostic and Statistical Manual of Mental Disorders—an exhaustive catalog of symptoms used by doctors to diagnose psychiatric illness. Gone from the latest revision are “attenuated psychosis syndrome,” intended to help identify individuals at risk of full-blown psychosis, and “mixed anxiety depressive disorder,” a blend of anxiety and depression symptoms. Both performed badly on field tests and in public comments gathered by the group in its march toward the May 2013 publication deadline. (agencies)

Deep belly fat may increase after liposuction

NEW YORK, May 10: A new study suggests that women who have liposuction to trim their tummies may gain some fat deeper within the abdomen—a type of fat that’s particularly unhealthy. Brazilian researchers found that within months of abdominal liposuction, there may be an increase in the so-called “visceral” fat that surrounds the abdominal organs. (agencies)

Anti-obesity program doesn’t help teen girls: study

NEW YORK, May 10: An intensive besity-prevention program for Australian girls didn’t lead to any improvements in their diet, physical activity or body weight a year later, according to a new report. Findings from the school-based intervention, which involved exercise sessions and nutrition workshops for lower-income girls, are the latest disappointment in a slew of research attempting to head-off adult obesity—and the disease risks that come with it. (agencies)

World disease fund gets added 1.6 billion dollars shot in arm

GENEVA, May 10: The Global Fund, a leading financier in the struggle against AIDS, tuberculosis and malaria, expects to have an additional 1.6 billion dollars to fund projects in 2012-2014, its new chief said yesterday, a turnaround from a funding freeze last year. “It’s a positive outlook where we did not have a positive outlook before,” the Fund’s General Manager Gabriel Jaramillo told. (agencies)

Probe finds collusion between India’s drug regulator, pharma firms

LONDON, May 10: GlaxoSmithKline will take its 2.6 billion dollars bid for long-time partner Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the US biotech group’s board. The decision to go hostile with the $13-a-share cash tender offer sets up GSK for a potentially lengthy battle with those Human Genome investors who believe it is not offering enough. (agencies)

US may speed approval of “breakthrough” drugs

WASHINGTON, May 10: Experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to US approval, under a proposal likely to become law this year. US drug regulators would be able to label such treatments “breakthrough” therapies, and work with companies to speed up clinical trials, for example by testing the drugs for a shorter time or enrolling fewer patients. (agencies)